Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $65.4950 (2.61%) ($65.4950 - $65.4950) on Fri. Jan. 22, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.81% (three month average) | RSI | 50 | Latest Price | $65.4950(2.61%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.9% a day on average for past five trading days. | Weekly Trend | EDIT declines -5.5% a week on average for past two weeks. | Market Behavior | Value stocks sell-off for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(66%) IWO(61%) IWC(59%) IBUY(58%) IWM(57%) | Factors Impacting EDIT price | EDIT will decline at least -3.905% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-13%) TBT(-7%) UNG(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -3.905% (StdDev 7.81%) | Hourly BBV | -0.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $55.31(-15.55%) | Resistance Level | $76.3 | 5 Day Moving Average | $69.87(-6.26%) | 10 Day Moving Average | $73.76(-11.21%) | 20 Day Moving Average | $76.3(-14.16%) | To recent high | -27.9% | To recent low | 136.3% | Market Cap | $4.067b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |